Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Pre-Close Trading Statement

7 Feb 2023 07:00

RNS Number : 0439P
East Imperial PLC
07 February 2023
 

7 February 2023

East Imperial PLC

(the "Group" or "Company")

Pre-Close Trading Statement

Strong revenue growth and operational progress in key markets; record performance over festive period

East Imperial, the global purveyor of ultra-premium mixers, announces a pre-close trading update for the year ending 31 December 2022 ("Period"), ahead of reporting its preliminary results in April 2023. The figures set out in this announcement are subject to audit.

The Group continued to deliver strong top line growth, with 2022 revenue increasing 15.5% year on year to approximately £3.2m, in line with expectations for the year. Revenues were driven by increased sales across all markets, with approximately 230,000 cases sold and greater revenue per unit.

In the key strategic US market, case sales were up 68% (+71% in Southern California) as the distribution agreement with Republic National Distributing Company began to bear fruit, bringing East Imperial products to new customers and responding to strong demand from the existing base. The appointment last November of The Lion Brewery as East Imperial's US bottling partner will enable East Imperial to benefit from significant cost savings as it expands in the fast-growing US market.

In East Imperial's well established APAC market, sales in the period were in line with the Board's expectations due to Covid lockdowns in the first half of the year. However, as restrictions lifted across the region, the Group has seen a strong return to growth in the second half. 

As the Chinese market reopens, East Imperial is well placed to continue to capitalise on demand from premium customers after signing a distribution agreement with Wen Hua Hang Wine Spirits Company in August 2022.

The Vietnam distribution agreement with SUTL Group announced in December 2022, further reiterates East Imperial's commitment to building a deep regional network across APAC and represents another important milestone for the Group with a region that is a leading destination for tourists.

In New Zealand, the Group experienced record sales and a strong performance in off-trade in the last quarter of 2022. This market is well placed for accelerated growth in 2023.

Innovation to expand the Group's ultra-premium product range continues to be a key differentiator. The Group's latest product, a Light Tonic Water, which was awarded a Difford's Guide 2023 Recommendation award, is now available in the US following a successful launch in New Zealand.

Looking ahead to 2023, whilst market conditions will continue to have an impact on margins, the pressure has eased in the last quarter due to a softening of freight charges, and this margin improvement has continued into 2023. The Group remains laser-focused on margin improvement opportunities in the medium term, with bold initiatives underway to significantly reduce manufacturing costs.

 

 

Tony Burt, CEO of East Imperial, said:

"The double-digit revenue growth we experienced over the year is testament to excellent customer demand for our product in key markets as well as the strong operational foundations we have put in place.

2022 was a transformational year for our US business, with the expansion of our distribution network and the appointment of a bottling partner, and I am very excited about the potential for growth in the coming years.

We are a brand with a deep Asia-Pacific heritage and as borders opened in this region, demand for our ultra-premium product has soared. I was particularly pleased by record sales in our home market of New Zealand over the Christmas period.

This positive momentum is continuing into 2023, as we continue to benefit from the ongoing shift towards premiumisation across the beverage industry and we remain confident in our strategy of aiming to be the only ultra-premium choice for mixers in our markets.

After three years of Covid restrictions we feel that the shackles have been fully lifted and the path is now clear for us to resume an even greater growth trajectory."

 

 

Media Enquiries

Brunswick Group

Helen Smith +4420 7404 5959

Will Booth

Eastimperial@brunswickgroup.com

 

About East Imperial

Founded in New Zealand and Singapore in 2012, East Imperial produces a range of ultra-premium mixers that sell throughout APAC, US and EMEA. Guided by a clear strategy to capitalise on the growing demand for premiumisation across the beverage industry, East Imperial has sold over 20 million bottles in over 20 countries since its founding, with popular products including Old World Tonic, Grapefruit Tonic, Yuzu Tonic and Mombasa Ginger Beer. In 2022, East Imperial won 8 medals, with two awarded best in class at the coveted Tonic & Mixers Masters Competition in London.

The company was founded on the philosophy of creating exquisite products defined by heritage, tradition and authenticity. All products are made from the highest quality, all-natural ingredients, reflecting East Imperial's commitment to providing a sustainable product and minimising environmental impacts at every stage of the manufacturing process.

For more information about East Imperial and its ultra-premium mixers, visit eastimperial.co.uk.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVLFRIRIIV
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.